# Using Tumor Models to Determine Treatments

Source: https://onco.cc/trials/nct06813079/  
OnCo record `nct06813079` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of cobimetinib, ponatinib, brigatinib, selinexor and other drugs in pancreatic cancer, run by University Health Network, Toronto, now recruiting.

## Summary

Using Tumor Models to Determine Treatments is a phase 2, interventional study registered as NCT06813079 by University Health Network, Toronto, with a registry enrolment figure of 25 participants, started 2025-04-07 and due to reach its primary completion in 2028-02-17. Interventions recorded: Cobimetinib; Ponatinib; Brigatinib; Colchicine; Selinexor; Abemaciclib; Neratinib; Doxorubicin; Etoposide; Ceritinib. Conditions listed: Pancreatic Ductal Carcinoma; Advanced Cancer; Epithelial Tumor. Primary outcome: Objective response rate (ORR). Pancreatic eligibility wording from the registry: "Advanced inoperable malignant epithelial pancreatic ductal carcinomas (i". Sites: Canada. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06813079
- Phase: 2
- Setting: ADOPT: Adaptive Organoid-Based Precision Therapy Study in Pancreatic Cancer - A Prospective Single-Arm Phase II Trial
- Sponsor: University Health Network, Toronto
- Enrolled: 25

## Sources

- ClinicalTrials.gov NCT06813079: https://clinicaltrials.gov/study/NCT06813079

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Abemaciclib](https://onco.cc/drugs/abemaciclib/), [Brigatinib](https://onco.cc/drugs/brigatinib/), [Ceritinib](https://onco.cc/drugs/ceritinib/), [Cobimetinib](https://onco.cc/drugs/cobimetinib/), [Doxorubicin](https://onco.cc/drugs/doxorubicin/), [Etoposide](https://onco.cc/drugs/etoposide/), [Neratinib](https://onco.cc/drugs/neratinib/), [Ponatinib](https://onco.cc/drugs/ponatinib/), [Selinexor](https://onco.cc/drugs/selinexor/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06813079.json